Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China · Delayed Price · Currency is CNY

17.50

+0.74 (4.42%)

Feb 13, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
New HIV Drug (Enomide Tablets)	133.54M
New HIV Drug (Enomide Tablets) Growth	173.41%
Medicines (Urokinase Injection)	80.04M
Senna Granules	55.36M
Senna Granules Growth	-13.99%
Ulinastatin Crude	50.47M
Ulinastatin Crude Growth	-36.56%
Crude Urokinase	45.15M
Crude Urokinase Growth	-74.49%
Other Human Protein Crude	17.46M
Other Human Protein Crude Growth	443.30%
New HIV Drug (AnovirinTablets)	16.36M
New HIV Drug (AnovirinTablets) Growth	-33.87%
Other Drugs	11.55M
HIV Diagnostic Reagents	3.35M
HIV Diagnostic Reagents Growth	-53.72%
Other	4.53M
Other Growth	11433.48%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	417.80M
China Growth	1.57%